Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

preCARDIA Enrolls First Patient in Early Feasibility Study

August 15, 2019

News Industry News

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

July 25, 2019

News Industry News

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

July 22, 2019

News Industry News

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

July 15, 2019

News Industry News

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

June 26, 2019

News Industry News

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

August 27, 2018

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Industry News

Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure

June 13, 2016

News Industry News

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

June 06, 2016

News Industry News

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

May 12, 2016

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Industry News

St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations

April 04, 2016

News Industry News

St. Jude Medical Announces CE Mark for MRI Compatibility on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients

December 01, 2015

News Industry News

New Long-term Data Published in The Lancet Further Demonstrates Superiority of the CardioMEMS HF System over Standard of Care

November 08, 2015

News Industry News

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

October 27, 2015

Advertisement

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

preCARDIA Enrolls First Patient in Early Feasibility Study

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations

St. Jude Medical Announces CE Mark for MRI Compatibility on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients

New Long-term Data Published in The Lancet Further Demonstrates Superiority of the CardioMEMS HF System over Standard of Care

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content